Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(2015)The global burden of cancer 2013 JAMA Oncol 1 505-527

[3] Siegel RL(1985)A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer Ann Thorac Surg 39 260-265

[4] Ferlay J(2016)Impact of surgery for stage IA non-small-cell lung cancer on patient quality of life J Community Support Oncol 14 37-44

[5] Lortet-Tieulent J(2014)Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications Radiother Oncol 112 256-261

[6] Jemal A(2005)Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 1427-1431

[7] Fitzmaurice C(2015)Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan clinical oncology group study JCOG0403 Int J Radiat Oncol Biol Phys 93 989-996

[8] Dicker D(2015)Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Lancet Oncol 16 630-637

[9] Pain A(2016)Clinical outcomes of video-assisted thoracic surgery and stereotactic body radiation therapy for early-stage non-small cell lung cancer: a meta-analysis Thorac Cancer 7 442-451

[10] Nakahara K(1987)A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373-383

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(2015)The global burden of cancer 2013 JAMA Oncol 1 505-527

[3] Siegel RL(1985)A method for predicting postoperative lung function and its relation to postoperative complications in patients with lung cancer Ann Thorac Surg 39 260-265

[4] Ferlay J(2016)Impact of surgery for stage IA non-small-cell lung cancer on patient quality of life J Community Support Oncol 14 37-44

[5] Lortet-Tieulent J(2014)Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications Radiother Oncol 112 256-261

[6] Jemal A(2005)Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 1427-1431

[7] Fitzmaurice C(2015)Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan clinical oncology group study JCOG0403 Int J Radiat Oncol Biol Phys 93 989-996

[8] Dicker D(2015)Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Lancet Oncol 16 630-637

[9] Pain A(2016)Clinical outcomes of video-assisted thoracic surgery and stereotactic body radiation therapy for early-stage non-small cell lung cancer: a meta-analysis Thorac Cancer 7 442-451

[10] Nakahara K(1987)A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373-383